Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern

The global coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spawned an ongoing demand for new research reagents and interventions. Herein we describe a panel of monoclonal antibodies raised against SARS-CoV-2. One antibody sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Mahali S., Yan, Kexin, Le, Thuy T., Johnston, Ryan A., Amarilla, Alberto A., Muller, David A., McMillan, Christopher L. D., Modhiran, Naphak, Watterson, Daniel, Potter, James R., Sng, Julian D.J., Lor, Mary, Paramitha, Devina, Isaacs, Ariel, Khromykh, Alexander A., Hall, Roy A., Suhrbier, Andreas, Rawle, Daniel J., Hobson-Peters, Jody
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863740/
https://www.ncbi.nlm.nih.gov/pubmed/36680179
http://dx.doi.org/10.3390/v15010139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863740/
https://www.ncbi.nlm.nih.gov/pubmed/36680179
http://dx.doi.org/10.3390/v15010139

Ejemplares similares